In addition, research has shown that individuals with genetic susceptibility—such as those carrying null genotypes of GSTM1 and GSTT1—have reduced detoxification capacity and are more likely to experience DNA damage after exposure to carcinogens like heterocyclic amines (HCAs), leading to a significantly increased risk of breast cancer (45). Here, GSTM1 is linked to breast carcinoma.